Biolexis Therapeutics
Biolexis Therapeutics is a startup headquartered in Lehi, United States, founded in 2021. It has raised at least $3.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Biolexis Therapeutics has raised at least $3.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Biolexis Therapeutics sits inside the Salt Lake City region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Lehi
- Carketa
- Droplet Solutions
- Enzy Technologies
- Gabb Wireless
- Leland
- Limble Solutions
- MokiMobility
- PerkCity
- Podium
- Qualiti
- Remi Labs
Related
- Innovation profile of Lehi
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Biolexis Therapeutics do?
Biolexis Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Biolexis Therapeutics raised?
At least $3.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Biolexis Therapeutics based?
Biolexis Therapeutics is headquartered in Lehi, United States.
When was Biolexis Therapeutics founded?
Biolexis Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.